Parul Bhargava, MD
Pathology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 33 years
- Graduated 1993
Offices
1 location · University of California San Francisco · 1,780 clinicians in this group
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhargava’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$6,682
Medicare paid this office $6,682 for 59 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,861 | $25 |
| Microscopic genetic analysis of tumor, manual | 17 | $805 | $37 |
| Pathology examination of tissue using a microscope, intermediate complexity | 16 | $692 | $33 |
| Bone marrow, smear interpretation | 15 | $636 | $42 |
| Special stained specimen slides to examine tissue, initial procedure | 19 | $587 | $31 |
See all 7 services
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,861 | $25 |
| Microscopic genetic analysis of tumor, manual | 17 | $805 | $37 |
| Pathology examination of tissue using a microscope, intermediate complexity | 16 | $692 | $33 |
| Bone marrow, smear interpretation | 15 | $636 | $42 |
| Special stained specimen slides to examine tissue, initial procedure | 19 | $587 | $31 |
| Blood smear interpretation by physician with written report | 16 | $362 | $21 |
| Cell examination of specimen, concentration technique | 12 | $240 | $20 |
Who their Medicare patients are
59 Original Medicare patients in 2024. Average age 73 · Women 42% · Also on Medicaid 31% · Health risk score 3.25. Sicker patients than 9 in 10 peers; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Chronic kidney disease 47% · Coronary heart disease 37% · Diabetes 36% · Heart failure 29% · COPD 24% · Atrial fibrillation 24% · Stroke 20% · Depression 19%.
The office billed $50,445, Medicare allowed $8,377 and paid $6,682; for 214 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 59 | 214 | 73 | 3.25 | $50,445 | $6,682 |
| 2023 | 93 | 468 | 71 | 2.51 | $110,068 | $15,035 |
| 2022 | 84 | 464 | 70 | 3.02 | $99,911 | $14,239 |
| 2021 | 83 | 344 | 72 | 2.76 | $76,026 | $11,022 |
| 2020 | 86 | 245 | 72 | 3.47 | $51,349 | $7,722 |
| 2019 | 124 | 358 | 69 | 3.31 | $73,727 | $11,247 |
| 2018 | 129 | 332 | 67 | 3.27 | $64,801 | $10,147 |
| 2017 | 115 | 458 | 71 | 2.29 | $76,434 | $15,950 |
| 2016 | 211 | 939 | 70 | 2.09 | $151,252 | $32,396 |
| 2015 | 187 | 875 | 71 | 2.13 | $140,096 | $27,910 |
| 2014 | 134 | 771 | 71 | 2.17 | $88,310 | $21,176 |
| 2013 | 139 | 812 | 73 | 1.78 | $106,567 | $27,765 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Special stained specimen slides to examine tissue, each additional procedure | 41 | $3,893 | $26 |
| Pathology examination of tissue using a microscope, intermediate complexity | 40 | $2,157 | $34 |
| Microscopic genetic analysis of tumor, manual | 41 | $2,075 | $38 |
| Bone marrow, smear interpretation | 39 | $1,746 | $44 |
| Special stained specimen slides to examine tissue, initial procedure | 45 | $1,481 | $32 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 11 | $907 | $76 |
| Blood smear interpretation by physician with written report | 21 | $434 | $21 |
| Special stained specimen slides to examine tissue including interpretation and report | 19 | $270 | $11 |
| Cell examination of specimen, concentration technique | 11 | $223 | $19 |
2022: 7 services
| Special stained specimen slides to examine tissue, each additional procedure | 36 | $4,556 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 33 | $2,134 | $34 |
| Microscopic genetic analysis of tumor, manual | 32 | $1,689 | $38 |
| Bone marrow, smear interpretation | 30 | $1,298 | $43 |
| Special stained specimen slides to examine tissue, initial procedure | 39 | $1,283 | $31 |
| Blood smear interpretation by physician with written report | 27 | $607 | $22 |
| Special stained specimen slides to examine tissue including interpretation and report | 14 | $195 | $11 |
2021: 8 services
| Special stained specimen slides to examine tissue, each additional procedure | 23 | $2,152 | $26 |
| Pathology examination of tissue using a microscope, intermediate complexity | 28 | $1,966 | $34 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 16 | $1,224 | $77 |
| Microscopic genetic analysis of tumor, manual | 25 | $1,198 | $39 |
| Bone marrow, smear interpretation | 27 | $1,173 | $42 |
| Blood smear interpretation by physician with written report | 52 | $1,101 | $20 |
| Special stained specimen slides to examine tissue, initial procedure | 29 | $1,034 | $32 |
| Special stained specimen slides to examine tissue including interpretation and report | 11 | $188 | $11 |
2020: 6 services
| Special stained specimen slides to examine tissue, each additional procedure | 13 | $1,796 | $27 |
| Blood smear interpretation by physician with written report | 58 | $1,280 | $22 |
| Microscopic genetic analysis of tumor, manual | 13 | $754 | $40 |
| Pathology examination of tissue using a microscope, intermediate complexity | 11 | $745 | $35 |
| Special stained specimen slides to examine tissue, initial procedure | 15 | $533 | $33 |
| Bone marrow, smear interpretation | 11 | $501 | $46 |
2019: 8 services
| Special stained specimen slides to examine tissue, each additional procedure | 24 | $2,417 | $27 |
| Blood smear interpretation by physician with written report | 78 | $1,757 | $22 |
| Pathology examination of tissue using a microscope, intermediate complexity | 25 | $1,663 | $35 |
| Microscopic genetic analysis of tumor, manual | 24 | $1,067 | $40 |
| Bone marrow, smear interpretation | 22 | $1,041 | $45 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 12 | $925 | $77 |
| Special stained specimen slides to examine tissue, initial procedure | 24 | $828 | $33 |
| Coagulation function screening test with interpretation and report | 14 | $474 | $32 |
2018: 7 services
| Pathology examination of tissue using a microscope, intermediate complexity | 24 | $1,817 | $36 |
| Blood smear interpretation by physician with written report | 72 | $1,807 | $22 |
| Special stained specimen slides to examine tissue, each additional procedure | 20 | $1,342 | $27 |
| Microscopic genetic analysis of tumor, manual | 22 | $1,221 | $42 |
| Bone marrow, smear interpretation | 23 | $1,003 | $44 |
| Special stained specimen slides to examine tissue, initial procedure | 23 | $870 | $33 |
| Screening examination of specimen cells, screening and interpretation | 26 | $641 | $23 |
2017: 8 services
| Special stained specimen slides to examine tissue, each additional procedure | 31 | $5,091 | $25 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 42 | $3,562 | $71 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 20 | $1,401 | $64 |
| Pathology examination of tissue using a microscope, intermediate complexity | 30 | $1,175 | $33 |
| Special stained specimen slides to examine tissue, initial procedure | 31 | $1,092 | $31 |
| Bone marrow, smear interpretation | 21 | $899 | $41 |
| Blood smear interpretation by physician with written report | 15 | $380 | $22 |
| Preparation of tissue for examination by removing any calcium present | 17 | $192 | $11 |
2016: 11 services
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 97 | $9,896 | $92 |
| Special stained specimen slides to examine tissue, each additional procedure | 67 | $8,880 | $22 |
| Pathology examination of tissue using a microscope, intermediate complexity | 68 | $2,638 | $31 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 34 | $2,566 | $75 |
| Special stained specimen slides to examine tissue, initial procedure | 68 | $2,231 | $30 |
| Bone marrow, smear interpretation | 51 | $2,038 | $37 |
| Genetic sequencing localization, initial procedure | 17 | $674 | $37 |
| Preparation of tissue for examination by removing any calcium present | 51 | $576 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 31 | $414 | $10 |
| Blood smear interpretation by physician with written report | 12 | $272 | $21 |
| Hemoglobin analysis and measurement, electrophoresis | 16 | $225 | $14 |
2015: 12 services
| Special stained specimen slides to examine tissue, each additional procedure | 61 | $6,207 | $17 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 67 | $5,133 | $73 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 50 | $4,968 | $90 |
| Bone marrow, smear interpretation | 57 | $2,482 | $39 |
| Pathology examination of tissue using a microscope, intermediate complexity | 65 | $2,248 | $31 |
| Special stained specimen slides to examine tissue, initial procedure | 63 | $1,945 | $29 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 25 | $1,511 | $58 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 12 | $841 | $70 |
| Preparation of tissue for examination by removing any calcium present | 51 | $564 | $10 |
| Genetic sequencing localization, initial procedure | 13 | $466 | $36 |
| Special stained specimen slides to examine tissue including interpretation and report | 34 | $453 | $10 |
| Blood smear interpretation by physician with written report | 14 | $327 | $20 |
2014: 12 services
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 31 | $3,195 | $89 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 55 | $3,124 | $10 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 35 | $2,869 | $70 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 34 | $2,448 | $58 |
| Bone marrow, smear interpretation | 50 | $2,301 | $40 |
| Pathology examination of tissue using a microscope, intermediate complexity | 59 | $2,196 | $31 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 57 | $1,578 | $25 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 13 | $908 | $70 |
| Genetic sequencing localization, initial procedure | 11 | $682 | $49 |
| Preparation of tissue for examination by removing any calcium present | 44 | $489 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 31 | $434 | $10 |
| Blood smear interpretation by physician with written report | 14 | $304 | $20 |
2013: 10 services
| Special stained specimen slides to examine tissue, initial procedure | 65 | $14,394 | $35 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 37 | $2,658 | $72 |
| Pathology examination of tissue using a microscope, intermediate complexity | 71 | $2,371 | $30 |
| Bone marrow, smear interpretation | 52 | $2,309 | $39 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 30 | $1,638 | $55 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 12 | $1,128 | $87 |
| Preparation of tissue for examination by removing any calcium present | 55 | $626 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 41 | $499 | $10 |
| Blood smear interpretation by physician with written report | 13 | $299 | $20 |
| Hemoglobin analysis and measurement, electrophoresis | 18 | $281 | $16 |
Medicaid work
$324,242 in 2024
Medicaid paid $324,242 for 43,960 billed services this clinician did in 2024, up to 734 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 232 | $37,884 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 643 | $35,282 |
| Blood gases measurement | 955 | $21,986 |
| COMPREHENSIVE METABOLIC PANEL | 2,568 | $16,606 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 2,862 | $15,722 |
| Lactate (lactic acid) | 793 | $9,976 |
| Measurement of alkaline phosphatase | 2,963 | $9,219 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; quantification, each organism | 287 | $9,077 |
| Creatinine; blood | 3,034 | $8,800 |
| Measurement of tacrolimus | 822 | $7,047 |
| Measurement of triglycerides | 1,778 | $6,878 |
| THROMBOPLASTIN TIME PARTIAL | 1,231 | $6,319 |
| 2024 | 43,960 | 148 | 734 | $324,242 |
| 2023 | 302,980 | 167 | 673 | $1,622,375 |
| 2022 | 324,097 | 186 | 1,294 | $1,574,548 |
| 2021 | 382,394 | 181 | 1,283 | $1,849,650 |
| 2020 | 80,270 | 157 | 958 | $353,438 |
| 2018 | 13 | 1 | 13 | $213 |
See the largest Medicaid services in earlier years
2023
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 4,919 | $220,199 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 1,182 | $172,077 |
| Blood gases measurement | 7,711 | $119,362 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 21,221 | $83,753 |
| COMPREHENSIVE METABOLIC PANEL | 16,083 | $70,660 |
| Lactate (lactic acid) | 6,082 | $57,641 |
| Creatinine; blood | 19,462 | $49,784 |
| Measurement of alkaline phosphatase | 20,224 | $47,187 |
| Measurement of triglycerides | 14,069 | $35,806 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; quantification, each organism | 1,330 | $27,971 |
| Measurement of tacrolimus | 5,000 | $25,575 |
| THROMBOPLASTIN TIME PARTIAL | 7,869 | $24,954 |
2022
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 1,232 | $169,238 |
| Blood gases measurement | 8,029 | $123,756 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 21,245 | $81,812 |
| COMPREHENSIVE METABOLIC PANEL | 15,919 | $69,328 |
| Lactate (lactic acid) | 6,580 | $62,073 |
| Creatinine; blood | 21,595 | $56,933 |
| Measurement of alkaline phosphatase | 18,952 | $44,712 |
| Measurement of triglycerides | 15,660 | $40,783 |
| Measurement of vitamin D 25 hydroxy | 2,476 | $29,665 |
| Thyroid stimulating hormone (TSH) | 3,489 | $24,015 |
| THROMBOPLASTIN TIME PARTIAL | 7,756 | $23,862 |
| Stem cells (ie, CD34), total count | 1,012 | $22,173 |
2021
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 1,066 | $138,494 |
| Blood gases measurement | 8,285 | $117,043 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 22,763 | $91,664 |
| COMPREHENSIVE METABOLIC PANEL | 17,111 | $77,253 |
| Creatinine; blood | 27,094 | $73,582 |
| Lactate (lactic acid) | 6,463 | $58,502 |
| Measurement of alkaline phosphatase | 19,239 | $48,077 |
| Measurement of triglycerides | 16,267 | $44,242 |
| Measurement of vitamin D 25 hydroxy | 3,812 | $42,601 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 2,193 | $35,985 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 2,193 | $35,965 |
| Thyroid stimulating hormone (TSH) | 4,803 | $33,595 |
2020
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 181 | $25,148 |
| Blood gases measurement | 1,798 | $20,535 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 4,820 | $18,729 |
| Creatinine; blood | 5,897 | $15,340 |
| COMPREHENSIVE METABOLIC PANEL | 3,628 | $15,117 |
| Lactate (lactic acid) | 1,415 | $12,198 |
| Measurement of alkaline phosphatase | 4,432 | $10,359 |
| Measurement of triglycerides | 3,782 | $9,316 |
| Measurement of vitamin D 25 hydroxy | 724 | $8,098 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 407 | $6,799 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 407 | $6,776 |
| Thyroid stimulating hormone (TSH) | 905 | $6,303 |
2018
| Blood smear, peripheral, interpretation by physician with written report | 13 | $213 |
Money from drug and device companies
$4,000 in 2024
| 2024 | 1 | 2 | $4,000 | $4,000 |
| 2022 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sysmex America | Automated Hematology Analyzer Xn Series Xn-10 | $4,000 | 2 payments
|
See all 2 published payments
| Sysmex America | Honoraria · 2024-09-16 | Automated Hematology Analyzer Xn Series Xn-10 | $1,500 |
| Sysmex America | Honoraria · 2024-06-20 | Automated Hematology Analyzer Xn Series Xn-10 | $2,500 |
See earlier years (2022)
2022: $125
| Janssen Pharmaceuticals | Xarelto | $125 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871531145
- Licence
- MA 208170
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 330 Brookline Ave./Pathology, B.I. Deaconess Med Ctr/Ya309/E, Boston, MA, 02215
- NPI first listed
- 2006-06-02
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.